NCT06117254 Hearing Aids for Veterans With Functional Hearing Difficulties
| NCT ID | NCT06117254 |
| Status | Recruiting |
| Phase | — |
| Sponsor | VA Office of Research and Development |
| Condition | Auditory Processing Disorder |
| Study Type | INTERVENTIONAL |
| Enrollment | 142 participants |
| Start Date | 2025-03-09 |
| Primary Completion | 2027-10-29 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 142 participants in total. It began in 2025-03-09 with a primary completion date of 2027-10-29.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Every year, approximately 100,000 Veterans seek help at VA Audiology clinics for hearing and communication difficulties only to learn that they have normal hearing sensitivity. Unfortunately, there are very few established options to improve hearing and listening for these patients. To address this need, audiologists are increasingly prescribing hearing aids set to provide a small amount of amplification. Patients may benefit from the amplification or from modern hearing aid features such as noise reduction technology and the ability to stream sounds from a desired sound source directly to their ears thus reducing the background noise. This project will help to determine if prescribing hearing aids to patients without hearing loss is, in fact, beneficial and if so, why. It will also help to determine if some patients benefit more from hearing aids than others so that in the future, rehabilitation strategies can be better targeted toward individuals.
Eligibility Criteria
Inclusion Criteria: * Veteran eligible for VA Healthcare * Ability to travel to VA Portland Medical Center for repeated visits * Pure-tone thresholds of no more than 30 dB HL at frequencies between 500 and 3000 Hz, and no more than 40 dB HL at 4000 Hz * HHIA scores of 24 or greater indicating moderate to significant perceived hearing handicap Exclusion Criteria: * Conductive hearing loss or other significant otologic problems * Non-native English speakers * Inability to perform experimental tasks * Pure-tone interaural threshold asymmetries greater than 15 dB between 250 and 4000 Hz
Contact & Investigator
Melissa A Papesh, PhD
PRINCIPAL INVESTIGATOR
VA Portland Health Care System, Portland, OR
Frequently Asked Questions
Who can join the NCT06117254 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 79 Years, studying Auditory Processing Disorder. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06117254 currently recruiting?
Yes, NCT06117254 is actively recruiting participants. Contact the research team at Melissa.Papesh@va.gov for enrollment information.
Where is the NCT06117254 trial being conducted?
This trial is being conducted at Portland, United States.
Who is sponsoring the NCT06117254 clinical trial?
NCT06117254 is sponsored by VA Office of Research and Development. The principal investigator is Melissa A Papesh, PhD at VA Portland Health Care System, Portland, OR. The trial plans to enroll 142 participants.